By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Identifying and advancing transformative medicines to treat patients502.08M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States362.5M72.20%
Europe, Middle East, and Africa (EMEA)127.03M25.30%
Asia-Pacific (APAC)12.55M2.50%